1. Mono and polichemotherapy in the treatment of metastatic and invasive gestational trophoblastic disease: analysis of 50 cases.
- Author
-
de Andrade JM, Murta EF, de Freitas MM, Pires CR, and Bighetti S
- Subjects
- Adolescent, Adult, Chlorambucil administration & dosage, Dactinomycin administration & dosage, Female, Humans, Methotrexate administration & dosage, Middle Aged, Neoplasm Invasiveness, Neoplasm Metastasis, Pregnancy, Trophoblastic Neoplasms pathology, Uterine Neoplasms pathology, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Trophoblastic Neoplasms drug therapy, Uterine Neoplasms drug therapy
- Abstract
Fifty patients with metastatic or invasive gestational trophoblastic disease (GTD) were admitted at the "Hospital das Clínicas" of the Ribeirão Preto School of Medicine of the São Paulo University between January 1980 and December 1990. Of these 50 patients, 44 (88%) had GTD following abortion, 5 (10%) after term pregnancies and one (2%) after an ectopic pregnancy. Thirty five (70%) had invasive GTD and 15 (30%) metastatic GTD. The sites of metastases were: lung, 8 (53.3%), pelvis, 4 (26.6%), central nervous system, 2 (13.3%) and right auricle, 1 (6.6%). Human chorionic gonadotropin, pelvic arteriography and ultrasonography were used in the diagnosis of invasive GTD. 25 of the 41 patients with low-risk metastatic and invasive GTD were treated with monochemotherapy. There were 6 (24%) failures and the remaining 19 patients (76%) had complete remission of the disease after 2.89 mean cycles. Sixteen patients were treated with polichemotherapy, there were 2 (12.5%) failures and the remaining 14 had complete remission after a 2.3 mean cycles. No statistical differences between the two types of chemotherapy were observed. Four (8%) deaths were recorded.
- Published
- 1993